Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-06

FDA Approved: VISINE ALLERGY EYE RELIEF MULTI-ACTION — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

The FDA approved a supplemental application for Visine Allergy Eye Relief Multi-Action, a combination eye drop containing naphazoline hydrochloride and pheniram…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VISINE ALLERGY EYE RELIEF MULTI-ACTION (Naphazoline hydrochloride and pheniramine maleate)

Snippet

SUPPL AP for VISINE ALLERGY EYE RELIEF MULTI-ACTION (NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE)